VYNE Therapeutics Inc. Quarterly Marketable Securities, Current in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
VYNE Therapeutics Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2019 to Q2 2024.
  • VYNE Therapeutics Inc. Marketable Securities, Current for the quarter ending June 30, 2024 was $48.5M.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $48.5M Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $66.9M Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $62.6M +$62.6M Dec 31, 2023 10-Q 2024-08-14
Q4 2022 $0 $0 Dec 31, 2022 10-K 2024-03-01
Q4 2021 $0 -$1.03M -100% Dec 31, 2021 10-K 2022-03-17
Q3 2021 $0 -$3.05M -100% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $0 -$2.61M -100% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $1.03M -$22.8M -95.7% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.03M -$15.2M -93.7% Dec 31, 2020 10-K 2022-03-17
Q3 2020 $3.05M Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.61M Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $23.8M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $16.2M Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.